About Us


RRD was founded in 2002 to create an alternative approach to drug development, enabling more efficient use of capital and accelerating asset value whether it be human proof-of-concept (hPOC), or marketing approval.

Our Product Development Team (PDT) partnering model has a long track record of value creation by defining the right strategy and controlling operational execution for more predictable achievement of value.

Our expertise and experience spans the entire drug development process and combines rigorous scientific input, strategic insight, program management, and operational excellence to more rapidly achieve development milestones.

In 2020, RRD was acquired by Uniphar, a global diversified healthcare services company. The acquisition has enabled RRD to accelerate its growth through investment in its core development model as well as new capabilities that broaden RRD’s service offerings to its product development partners.